Volume 15, Issue 4 (December 2017)                   IRJ 2017, 15(4): 303-308 | Back to browse issues page

XML Print

1- Social Welfare Management Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
2- Department of Sociology, Faculty of Humanities and Social Sciences, Kharazmi University, Tehran, Iran.
3- Department of Social Sciences, Farhangian University, Tehran, Iran.
4- Substance Abuse and Dependence Research Centre, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
5- School of Medicine, Ziaeian Hospital, International Campus, Tehran University of Medical Sciences, Tehran, Iran
6- Student Research Center, International Campus, Tehran University of Medical Sciences, Tehran, Iran.
Abstract:   (631 Views)
Objectives: Dependence on Amphetamine-Type Stimulants (ATS) is a current health concern in Iran. The present study aimed to investigate the most needed treatment and rehabilitation services that a group of ATS-dependent patients in Tehran reported.
Methods: The current study is part of the first cross-sectional survey of the prevalence of ATS dependence in Tehran. A researcher-made questionnaire was used to collect data. Overall, 6027 men and women in the general adult population of Tehran were interviewed. Overall, 261 participants were ATS-dependent. Of them, 35 participants were interviewed in this qualitative study. Atlas-ti software was used for qualitative data analysis in compliance with the Grounded Theory of Strauss and Corbin.
Results: The mean age of the participants was 32 (SD=11) years (age range: 18-60 years). The mean year of the schooling was 8 (SD=9). The content analysis of interviews showed a series of needs including rehabilitation not only treatment, brief psychosocial treatments, family education and engagement in treatment and rehabilitation as well as after treatment services such as case management to help them to re-integrate into society respectively.
Discussion: The study results indicated that ATS dependence demands a combination of treatment and rehabilitation services. This concern demands long-term planning, designing and training, which should be considered by health service providers. Further studies are needed to determine which treatment or rehabilitation programme may work best for this group of drug-dependent people.
Full-Text [PDF 482 kb]   (350 Downloads) |   |   Full-Text (HTML)  (40 Views)  
Type of Study: Original Research Articles | Subject: Addiction
Received: 2017/03/10 | Accepted: 2017/07/3 | Published: 2017/12/1

1. United Nations Office on Drugs and Crime. World drug report. Vienna: United Nations Publications; 2014.
2. United Nations Office on Drugs and Crime. World drug report. Vienna: United Nations Publications; 2013.
3. Degenhardt L, Baxter AJ, Lee YY, Hall W, Sara GE, Johns N, et al. The global epidemiology and burden of psychostimulant dependence: Findings from the Global Burden of Disease Study 2010. Drug and Alcohol Dependence. 2014; 137:36–47. doi: 10.1016/j.drugalcdep.2013.12.025 [DOI:10.1016/j.drugalcdep.2013.12.025]
4. Degenhardt L, Mathers B, Guarinieri M, Panda S, Phillips B, Strathdee SA, et al. Meth/amphetamine use and associated HIV: Implications for global policy and public health. International Journal of Drug Policy. 2010; 21(5):347–58. doi: 10.1016/j.drugpo.2009.11.007 [DOI:10.1016/j.drugpo.2009.11.007]
5. Mehrjerdi ZA. Crystal in Iran: Methamphetamine or heroin kerack. DARU Journal of Pharmaceutical Sciences. 2013; 21(1):22. doi: 10.1186/2008-2231-21-22 [DOI:10.1186/2008-2231-21-22]
6. Alam Mehrjerdi Z, Mokri A, Dolan K. Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country. Asian Journal of Psychiatry. 2015; 16:17–25. doi: 10.1016/j.ajp.2015.05.036 [DOI:10.1016/j.ajp.2015.05.036]
7. Brensilver M, Heinzerling KG, Shoptaw S. Pharmacotherapy of amphetamine type stimulant dependence: An update. Drug and Alcohol Review. 2013; 32(5):449-60. doi: 10.1111/dar.12048 [DOI:10.1111/dar.12048]
8. Phillips KA, Epstein DH, Preston KL. Psychostimulant addiction treatment. Neuropharmacology. 2014; 87:150–60. doi: 10.1016/j.neuropharm.2014.04.002 [DOI:10.1016/j.neuropharm.2014.04.002]
9. Alam Mehrjerdi Z, Abarashi Z, Mansoori S, Deylamizadeh A, Salehi Fadardi J, Noroozi A, et al. Methamphetamine use among Iranian heroin kerack-dependent women: Implications for treatment. International Journal of High Risk Behaviors and Addiction. 2013; 2(1):15–21. doi: 10.5812/ijhrba.10216 [DOI:10.5812/ijhrba.10216]
10. Alam Mehrjerdi Z, Abarashi Z, Noroozi A, Arshad L, Zarghami M. Correlates of shared methamphetamine injection among methamphetamine injecting treatment seekers: The first report from Iran. International Journal of STD & AIDS . 2013; 25(6):420–7. doi: 10.1177/0956462413512806 [DOI:10.1177/0956462413512806]
11. Rawson RA, Huber A, McCann M, Shoptaw S, Farabee D, Reiber C, et al. A comparison of contingency management and cognitive behavioral approaches during methadone maintenance treatment for cocaine dependence. Archives of General Psychiatry. 2002; 59(9):817. doi: 10.1001/archpsyc.59.9.817 [DOI:10.1001/archpsyc.59.9.817]
12. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). New York: American Psychiatric Pub; 2013.
13. Strauss A, Corbin J. Basics of qualitative research techniques. California: Sage Publications; 1998.
14. Noori R, Daneshmand R, Farhoudian A, Ghaderi S, Aryanfard S, Moradi A. Amphetamine type stimulants in a group of adults in Tehran, Iran: a rapid situation assessment in twenty-two districts. Iranian Journal of Psychiatry and Behavioural Sciences. 2016; 10(4):e7704. doi: 10.17795/ijpbs-7704 [DOI:10.17795/ijpbs-7704]
15. Baker A, Boggs TG, Lewin TJ. Randomized controlled trial of brief cognitive behavioural interventions among regular users of amphetamine. Addiction. 2001; 96(9):1279–87. doi: 10.1046/j.1360-0443.2001.96912797.x [DOI:10.1046/j.1360-0443.2001.96912797.x]
16. Baker A, Lee NK, Claire M, Lewin TJ, Grant T, Pohlman S, et al. Brief cognitive behavioural interventions for regular amphetamine users: A step in the right direction. Addiction. 2005; 100(3):367–78. doi: 10.1111/j.1360-0443.2005.01002.x [DOI:10.1111/j.1360-0443.2005.01002.x]
17. Massah O, Effatpanah M, Shishehgar S. Matrix model for methamphetamine dependence among Iranian female methadone patients: The first report from the most populated Persian Gulf country. Iranian Rehabilitation Journal. 2017; 15(3):193-8. [DOI:10.29252/nrip.irj.15.3.193]
18. Sami S, Effatpanah M, Moradi A, Massah O. Matrix model as an intensive rehabilitation in three methadone services in Iran. Iranian Rehabilitation Journal. 2017; 15(3):293-8. [DOI:10.29252/nrip.irj.15.3.293]
19. Noori R, Massah O, Moazen B, Farhoudian A, Daneshmand R, Aryanfard S. Women only therapeutic community program and treatment needs in Iran: The first study from the most populated Persian Gulf country. Iranian Journal of Psychiatry and Behavioural Sciences. 2017; 11(2): e9273. doi: 10.5812/ijpbs.9273
20. Hill R. Evidence based practices for treatment of methamphetamine dependency: A review. Guelph: Community Engaged Scholarship Institute; 2015.
21. Rawson RA, Shoptaw SJ, Obert JL, McCann MJ, Hasson AL, Marinelli Casey PJ, et al. An intensive outpatient approach for cocaine abuse treatment. Journal of Substance Abuse Treatment. 1995; 12(2):117–27. doi: 10.1016/0740-5472(94)00080-b [DOI:10.1016/0740-5472(94)00080-B]
22. Huber A, Ling W, Shoptaw S, Gulati V, Brethen P, Rawson R. Integrating treatments for methamphetamine abuse: A psychosocial perspective. Journal of Addictive Diseases. 1997; 16(4):41–50. Doi: 10.1080/10550889709511142 [DOI:10.1080/10550889709511142]